Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gandelman
Mark Gandelman, Kfar-Saba IL
| Patent application number | Description | Published |
|---|---|---|
| 20100292084 | NOVEL DIARYLPHOSPHINE- AND DIALKYLPHOSPHINE-CONTAINING COMPOUNDS, PROCESSES OF PREPARING SAME AND USES THEREOF AS TRIDENTATE LIGANDS - A novel process of preparing tridentate ligands containing one or more of a diarylphosphine and/or dialkylphosphine electron donating groups are disclosed. Use of this process for preparing a combinatorial library of such tridentate ligands and of organometallic complexes containing same is also disclosed. Further disclosed are novel diarylphosphine-containing and dialkylphosphine-containing compounds that can serve as tridentate ligands (e.g., pincer ligands), combinatorial libraries of such tridentate ligands, organometallic complexes containing these ligands (e.g., pincer complexes), and combinatorial libraries of such complexes. Methods utilizing these libraries for screening for candidate organometallic catalysts are also disclosed. Novel precursor molecules useful for preparing the tridentate ligands and processes of preparing same are also disclosed. | 11-18-2010 |
| 20100292100 | NOVEL DIARYLPHOSPHINE-CONTAINING COMPOUNDS, PROCESSES OF PREPARING SAME AND USES THEREOF AS TRIDENTATE LIGANDS - A novel process of preparing tridentate ligands containing a diarylphosphine electron donating group are disclosed. Use of this process for preparing a combinatorial library of such tridentate ligands and of organometallic complexes containing same is also disclosed. Further disclosed are novel diarylphosphine-containing compounds that can serve as tridentate ligands (e.g., pincer ligands), combinatorial libraries of such tridentate ligands, organometallic complexes containing these ligands (e.g., pincer complexes), and combinatorial libraries of such complexes. Methods utilizing these libraries for screening for candidate organometallic catalysts are also disclosed. | 11-18-2010 |
Olga Gandelman, Cambridge GB
| Patent application number | Description | Published |
|---|---|---|
| 20100068739 | PH Tolerant Luciferase - Use of a luciferase that has a mutation of at least one amino acid selected from the group consisting of positions 14, 35, 182, 232 and 465, where the numbering is according to the sequence of the luciferase from | 03-18-2010 |
| 20110177513 | NUCLEIC ACID AMPLIFICATION - A method for determining the presence and/or amount of a first polynucleic acid in a sample comprising subjecting the sample to nucleic acid amplification in which product is detectable by the presence of a signal generated by polynucleic acid formation from the first polynucleotide characterised in that the nucleic acid amplification reaction is conducted, in the same reaction vessel, with a predetermined amount of a second polynucleic acid which is subjected to nucleic acid amplification, the product of which is detectable by the presence of the same signal generated by polynucleic acid formation from the second polynucleotide as that generated by polynucleic acid formation from the first polynucleotide and wherein the product of the second polynucleic acid is produced with different reaction kinetics from the product of the first polynucleic acid such that the second polynucleic acid acts as an internal control for the method. | 07-21-2011 |
Yosef Gandelman, Ashdod IL
| Patent application number | Description | Published |
|---|---|---|
| 20110213227 | WIRELESS MEDICAL MONITORING SYSTEM - A blood oxygen saturation level (SpO2) measurement subunit employed in a wireless transceiver unit connected to a medical monitor unit. An illumination emulator is used for emulating the characteristics of an illumination source of a pulse oximeter. The emulator utilities at least part of the energy coming from the SpO2 socket of the medical monitor. Energy originally intended to energize one illumination source of the pulse oximeter, energizes the power supply circuitry. A processor is employed for processing information about pulsing arterial blood of a patient received from a patient companion assembly (PCA). A digital to analogue converter is used for converting the PCA, to analogue signal. A low pass filter (LPF), filtering the signal to form a pulsative voltage signal represents the pulsing arterial blood of the patient, and is sent to the SpO2 socket of the medical monitor for displaying and further processing. | 09-01-2011 |